SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Apr 05, 2007	View HTML 0001144204-07-017414.pdf 0001144204-07-017414.rtf 0001144204-07-017414.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Apr 04, 2007	View HTML 0001144204-07-017169.pdf 0001144204-07-017169.rtf 0001144204-07-017169.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Apr 04, 2007	View HTML 0001144204-07-017171.pdf 0001144204-07-017171.rtf 0001144204-07-017171.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Apr 04, 2007	View HTML 0001144204-07-017207.pdf 0001144204-07-017207.rtf 0001144204-07-017207.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Apr 04, 2007	View HTML 0001144204-07-017280.pdf 0001144204-07-017280.rtf 0001144204-07-017280.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Apr 02, 2007	View HTML 0001144204-07-016437.pdf 0001144204-07-016437.rtf 0001144204-07-016437.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Mar 29, 2007	View HTML 0001144204-07-015182.pdf 0001144204-07-015182.rtf 0001144204-07-015182.xls
424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Mar 09, 2007	View HTML 0001144204-07-012072.pdf 0001144204-07-012072.rtf 0001144204-07-012072.xls
EFFECT	EFFECT	Mar 09, 2007	View HTML 9999999995-07-000890.pdf 9999999995-07-000890.rtf
EFFECT	EFFECT	Mar 09, 2007	View HTML 9999999995-07-000891.pdf 9999999995-07-000891.rtf

Data provided by Kaleidoscope.